[Federal Register Volume 81, Number 237 (Friday, December 9, 2016)]
[Notices]
[Pages 89087-89088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29514]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of U.S. Government-Owned 
Patents

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Army hereby gives notice of its intent 
to grant an exclusive, royalty-bearing, revocable license to pending 
United States Provisional Patent Application 62/343,315, entitled, 
``Zika Virus Vaccine and Methods of Production'' filed May 31, 2016 and 
an exclusive, royalty-bearing, revocable license to pending United 
States Provisional Patent Application 62/370,260, entitled, ``Zika 
Vaccine and Methods of Preparation'' filed August 3, 2016 to Sanofi 
Pasteur, Inc., having its principal place of business at 1 Discovery 
Drive, Swiftwater, PA 18370.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry 
Datlof, Office of Research & Technology Assessment, (301) 619-0033. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with

[[Page 89088]]

the Command Judge Advocate (see ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2016-29514 Filed 12-8-16; 8:45 am]
 BILLING CODE 5001-03-P